MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer-Reference-Cited by-同舟云学术

MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer

Published:2020-12-03 Issue:4 Volume:40 Page:833-847
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Han Jing,Qu Hongbo,Han Mingli,Ding Yichao,Xie Mingwei,Hu Jianguo,Chen Yuanwen,Dong Huaying^ORCID

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-020-01574-8.pdf

Reference48 articles.

1. Boero S, Morabito A, Banelli B, Cardinali B, Dozin B, Lunardi G, et al. Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcgammaRIIIA/FcgammaRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines. J Transl Med. 2015;13:324.

2. Li N, Deng Y, Zhou L, Tian T, Yang S, Wu Y, et al. Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017. J Hematol Oncol. 2019;12:140.

3. Bighin C, Pronzato P, Del Mastro L. Trastuzumab emtansine in the treatment of HER-2-positive metastatic breast cancer patients. Future Oncol. 2013;9:955–7.

4. Amadori D, Milandri C, Comella G, Saracchini S, Salvagni S, Barone C, et al. A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer. Eur J Cancer. 2011;47:2091–8.

5. Borst P. Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what? Open Biol. 2012;2:120066.

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting fatty acid oxidation enhances response to HER2-targeted therapy;Nature Communications;2024-08-03

2. Emerging roles of long noncoding RNAs in enzymes related intracellular metabolic pathways in cancer biology;Biomedicine & Pharmacotherapy;2024-07

3. Biological mechanisms of resistance to trastuzumab and ways to overcome them: Mod-ern problems of clinical oncology;Regulatory Mechanisms in Biosystems;2024-05-11

4. Acylcarnitines promote gallbladder cancer metastasis through lncBCL2L11-THOC5-JNK axis;Journal of Translational Medicine;2024-03-22

5. Harnessing the potential of long non-coding RNAs in breast cancer: from etiology to treatment resistance and clinical applications;Frontiers in Oncology;2024-03-05